We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
576
Marsh
MRSH
$94.3B
| $417K | 0.03% |
+2,400
| New | +$399K |
|
577
Phathom Pharmaceuticals
PHAT
$928M
| $417K | 0.03% |
21,200
+6,300
| +42% | +$148K |
|
|
SGEN
578
DELISTED
Seagen Inc. Common Stock
SGEN
| $417K | 0.03% |
+2,700
| New | +$452K |
|
579
The ONE Group
STKS
$55.9M
| $416K | 0.03% |
33,005
+4,205
| +15% | +$55.5K |
|
580
Community Health Systems
CYH
$382M
| $414K | 0.03% |
+31,119
| New | +$391K |
|
581
Carlyle Secured Lending
CGBD
$708M
| $413K | 0.03% |
30,107
+2,409
| +9% | +$33.4K |
|
582
Shattuck Labs
STTK
$646M
| $413K | 0.03% |
+48,578
| New | +$669K |
|
583
Kelly Services Class A
KELYA
$548M
| $410K | 0.03% |
+24,474
| New | +$447K |
|
584
Travere Therapeutics
TVTX
$5.17B
| $410K | 0.03% |
+13,209
| New | +$372K |
|
585
Aprea Therapeutics
APRE
$7.69M
| $409K | 0.03% |
7,130
+2,743
| +63% | +$242K |
|
586
Vera Bradley
VRA
$98.7M
| $409K | 0.03% |
48,013
+8,362
| +21% | +$80.5K |
|
|
WCN
587
Waste Connections
WCN
$43.6B
| $409K | 0.03% |
+3,000
| New | +$399K |
|
588
Accel Entertainment
ACEL
$1B
| $407K | 0.03% |
+31,296
| New | +$397K |
|
589
Rollins
ROL
$18.6B
| $407K | 0.03% |
+11,887
| New | +$416K |
|
590
Diodes
DIOD
$3.5B
| $406K | 0.03% |
+3,693
| New | +$374K |
|
591
Perella Weinberg Partners
PWP
$1.08B
| $405K | 0.03% |
+31,512
| New | +$415K |
|
|
592
Bruker
BRKR
$9.4B
| $403K | 0.03% |
4,800
-66,562
| -93% | -$5.34M |
|
|
VRTV
593
DELISTED
VERITIV CORPORATION
VRTV
| $403K | 0.03% |
+3,286
| New | +$396K |
|
|
ICPT
594
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $402K | 0.03% |
+24,657
| New | +$416K |
|
|
OCDX
595
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $401K | 0.03% |
18,734
+1,776
| +10% | +$35K |
|
596
Cable One
CABO
$237M
| $399K | 0.03% |
226
-174
| -44% | -$309K |
|
|
BRDG
597
DELISTED
Bridge Investment Group
BRDG
| $397K | 0.03% |
+15,905
| New | +$318K |
|
|
TRUE
598
DELISTED
TrueCar
TRUE
| $397K | 0.03% |
116,800
+27,254
| +30% | +$104K |
|
599
Black Diamond Therapeutics
BDTX
$95.1M
| $395K | 0.03% |
74,036
-27,844
| -27% | -$195K |
|
600
Intrepid Potash
IPI
$476M
| $393K | 0.03% |
+9,200
| New | +$391K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.